3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Chalazion
1
Interventions
tyramine-deoxysorbitol
1
Probiotics
1
Loteprednol Etabonate
1
Conservative Treatment
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Chalazion
×
tyramine-deoxysorbitol
×
Clear all
NCT03248440
2021-08-05
SUNRISE
Senju USA, Inc.
Phase 3
Completed
263 enrolled
7 charts